Study Investigating the Safety and Efficacy of Nalbuphine Extended-Release Tablets (NAL ER) for the Treatment of Cough in Idiopathic Pulmonary Fibrosis (IPF)
Study Investigating the Safety and Efficacy of Nalbuphine Extended-Release Tablets (NAL ER)
top of page
Search
Glenn Hearson
Nov 17, 2023
Efficacy and Safety of Orvepitant in Chronic Cough in Patients with Idiopathic Pulmonary Fibrosis
We have recently commenced a new study led at Nottingham University Hospitals NHS Trust by Gr Gauri Saini, to assess the efficacy and...
82
Glenn Hearson
May 25, 2023
Treating people with Idiopathic Pulmonary fibrosis with the Addition of Lansoprazole
We have just commenced recruiting patients into a new trial which funded by an NIHR HTA Grant with Chief Investigator Professor Andrew...
67
Glenn Hearson
May 17, 2023
Respiratory Research Day: Universities of Nottingham, Leicester and @NottmBRCLung, @LeicesterBRC
We want to say a huge thank you to everyone who attended the University of Nottingham & University of Leicester Joint Respiratory...
106
Glenn Hearson
Nov 11, 2022
New Body Plethysmography Box has arrived for ultra high quality, accurate lung function tests
Our brand new Vyntus Body Plethysmography Box or "Body Box" as we refer to it has finally arrived. Our lung function specialist, Paula...
85
Glenn Hearson
Aug 26, 2021
Study to assess remote monitoring of patients with an interstitial lung disease
We will be shortly commencing a new study to find out if it is practical for patients with a fibrotic lung disease, to take their own...
159
Glenn Hearson
Apr 12, 2021
Understanding Patient Priorities for Scientific Research on Pulmonary Fibrosis
Dr Amanda Goodwin , Dr Amanda Tatler and Dr Rachel Clifford , along with many other researchers in Translational Medical Science at the...
218
bottom of page